BioPorto Diagnostics

About:

BioPorto Diagnostics offers a wide range of diagnostic tests and antibodies to healthcare professionals in clinical and research settings.

Website: http://www.bioporto.com

Description:

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Their pioneering product portfolio includes assays for underserved disease states, such as NGAL for acute kidney injury. They sell their products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.

Total Funding Amount:

$11.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hellerup, Hovedstaden, Denmark

Founded Date:

1995-01-01

Contact Email:

info(AT)bioporto.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-06-18

IPO Status:

Public

Industries:

© 2025 bioDAO.ai